Sanofi India Board of Directors
Get the latest insights into the leadership at Sanofi India. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Aditya Narayan | Chairman |
| Rahul Bhatnagar | Non Executive Independent Director |
| Usha Thorat | Non Executive Independent Director |
| Rachid Ayari | Whole Time Director & Chief Financial Officer |
| Deepak Arora | Managing Director |
| Renee Amonkar | Whole Time Director & Site Director – Goa |
| Vaibhav Karandikar | Non Executive Director |
| Eric Mansion | Non Executive Director |
| Sudipta Chakraborty | Whole Time Director |
| Haresh Vala | Company Secretary & Compliance Officer |
| Rajani Kesari | Non Executive Independent Director |
| Mahadev Gawade | Whole Time Director & Site Director – Goa |
Sanofi India FAQs
The board at Sanofi India consists of experienced professionals, including Aditya Narayan, Rahul Bhatnagar, and others, overseeing the company’s strategic and corporate governance.
Directors at Sanofi India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Aditya Narayan is the current chairman at Sanofi India.
Executive directors at Sanofi India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sanofi India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sanofi India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
